Synovus Financial’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.18M Sell
15,595
-370
-2% -$50K 0.03% 355
2025
Q2
$2.01M Sell
15,965
-1,963
-11% -$245K 0.02% 355
2025
Q1
$2.45M Buy
17,928
+2,974
+20% +$425K 0.03% 310
2024
Q4
$2.29M Buy
14,954
+492
+3% +$83K 0.03% 327
2024
Q3
$2.8M Buy
14,462
+821
+6% +$172K 0.03% 327
2024
Q2
$3.16M Sell
13,641
-266
-2% -$57.8K 0.04% 266
2024
Q1
$3M Buy
13,907
+2,580
+23% +$604K 0.04% 275
2023
Q4
$2.93M Buy
11,327
+348
+3% +$85.5K 0.04% 262
2023
Q3
$2.82M Buy
10,979
+1,502
+16% +$402K 0.03% 282
2023
Q2
$2.7M Buy
9,477
+241
+3% +$71.7K 0.03% 298
2023
Q1
$2.57M Buy
9,236
+893
+11% +$247K 0.03% 297
2022
Q4
$2.31M Sell
8,343
-251
-3% -$70.9K 0.03% 317
2022
Q3
$2.3M Buy
8,594
+4,074
+90% +$865K 0.03% 294
2022
Q2
$915K Buy
4,520
+1,763
+64% +$360K 0.01% 447
2022
Q1
$581K Sell
2,757
-481
-15% -$105K 0.01% 584
2021
Q4
$779K Sell
3,238
-591
-15% -$152K 0.01% 514
2021
Q3
$1.08M Sell
3,829
-291
-7% -$95.4K 0.01% 421
2021
Q2
$1.43M Sell
4,120
-95
-2% -$28.8K 0.01% 354
2021
Q1
$1.18M Sell
4,215
-2,224
-35% -$600K 0.01% 346
2020
Q4
$1.56M Sell
6,439
-903
-12% -$233K 0.02% 315
2020
Q3
$2.08M Sell
7,342
-391
-5% -$109K 0.03% 244
2020
Q2
$2.07M Sell
7,733
-443
-5% -$133K 0.03% 227
2020
Q1
$2.59M Buy
8,176
+476
+6% +$144K 0.04% 229
2019
Q4
$2.28M Sell
7,700
-721
-9% -$200K 0.03% 226
2019
Q3
$1.95M Sell
8,421
-1,605
-16% -$374K 0.03% 229
2019
Q2
$2.34M Sell
10,026
-8,712
-46% -$2.01M 0.04% 203
2019
Q1
$4.44M Sell
18,738
-6,067
-24% -$1.91M 0.07% 143
2018
Q4
$7.49M Sell
24,805
-4,589
-16% -$1.46M 0.14% 101
2018
Q3
$10.4M Buy
29,394
+1,366
+5% +$470K 0.16% 91
2018
Q2
$8.15M Buy
28,028
+384
+1% +$108K 0.14% 102
2018
Q1
$7.57M Buy
27,644
+1,690
+7% +$525K 0.13% 106
2017
Q4
$8.28M Buy
25,954
+728
+3% +$234K 0.14% 98
2017
Q3
$7.9M Buy
25,226
+301
+1% +$89.1K 0.15% 97
2017
Q2
$6.77M Buy
24,925
+376
+2% +$99.4K 0.14% 101
2017
Q1
$6.71M Buy
24,549
+2,262
+10% +$640K 0.14% 102
2016
Q4
$6.32M Buy
22,287
+384
+2% +$114K 0.14% 100
2016
Q3
$6.86M Sell
21,903
-580
-3% -$172K 0.16% 91
2016
Q2
$5.42M Buy
22,483
+1,044
+5% +$275K 0.13% 101
2016
Q1
$5.6M Buy
21,439
+6,665
+45% +$1.76M 0.14% 97
2015
Q4
$4.53M Buy
14,774
+1,452
+11% +$417K 0.11% 111
2015
Q3
$3.89M Buy
13,322
+4,978
+60% +$1.64M 0.1% 118
2015
Q2
$3.37M Sell
8,344
-531
-6% -$213K 0.09% 134
2015
Q1
$3.75M Buy
8,875
+7,487
+539% +$2.95M 0.1% 132
2014
Q4
$471K Buy
1,388
+11
+0.8% +$3.56K 0.01% 354
2014
Q3
$456K Buy
1,377
+1,218
+766% +$402K 0.01% 351
2014
Q2
$51K Sell
159
-198
-55% -$59.6K ﹤0.01% 575
2014
Q1
$109K Buy
357
+84
+31% +$26.7K ﹤0.01% 474
2013
Q4
$76K Hold
273
﹤0.01% 487
2013
Q3
$66K Hold
273
﹤0.01% 490
2013
Q2
$59K Buy
+273
New +$58.3K ﹤0.01% 491

Other funds holding BIIB